TXNIP and Hyperglycemia: In this study, the protein level of inflammasome components, NLRP3 and ASC, was not affected by Exendin-4-treated hyperglycemia cultured cardiomyocytes, while the upstream activator of inflammasome, TXNIP, was downregulated significantly [22, 24].